Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3913]

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated...

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )

EUROCARE-5 results show large variations in survival from blood cancers between...

Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy

EUROCARE-5 results show large variations in survival from blood cancers between European countries ( Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy )

Atrial fibrillation in CLL patients on ibrutinib

Prof Florence Cymbalista – University of Paris, Paris, France

Atrial fibrillation in CLL patients on ibrutinib ( Prof Florence Cymbalista – University of Paris, Paris, France )

Circulating levels of tumour DNA in plasma may help monitor treatment response...

Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia

Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL ( Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia )

Cytogenetic and proteomic prognostic markers of CLL

Dr Lauren Thurgood - Flinders University, Adelaide, South Australia

Cytogenetic and proteomic prognostic markers of CLL ( Dr Lauren Thurgood - Flinders University, Adelaide, South Australia )

Expert panel discussion: The best of iwCLL 2015

Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai

Expert panel discussion: The best of iwCLL 2015 ( Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai )

Results of subgroup analysis of the HELIOS trial

Dr Paula Cramer – University of Cologne, Cologne, Germany

Results of subgroup analysis of the HELIOS trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )

Primary results from the MABLE phase IIIb study

Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France

Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi...

Dr Amy Johnson – The Ohio State University, Columbus, USA

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )

Results of a new phase Ib trial of voxtalisib in combination with...

Prof Farrukh Awan - Ohio State University, Columbus, USA

Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )

History of the B-cell in its 50th anniversary year

Prof Max Cooper - Emory University, Atlanta, USA

History of the B-cell in its 50th anniversary year ( Prof Max Cooper - Emory University, Atlanta, USA )

Human B-cell receptor structure and function in CLL

Prof Freda Stevenson - University of Southampton, Southampton, UK

Human B-cell receptor structure and function in CLL ( Prof Freda Stevenson - University of Southampton, Southampton, UK )

More from ecancer